Clinical behavior of implant infections due to Staphylococcus epidermidis

International Journal of Artificial Organs

Volumn 28, Issue 11, 2005, Pages 1110-1118

  Presterl, Elisabeth ^a,b   Lassnigg, A ^a,b   Parschalk, B ^a   Yassin, F ^a   Adametz, H ^a   Graninger, W ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Biofilm; Clinical features; Implant infection; Staphylococcus epidermidis

Indexed keywords

ANTIBIOTICS; BACTERIA; BIOFILMS; DIAGNOSIS; IMPLANTS (SURGICAL); SURGERY;

ANTIMICROBIAL SUSCEPTIBILITY; BACTERIAL BIOFILM; BLOOD CULTURE; CLINICAL FEATURES; FOREIGN MATERIALS; HEALTHY VOLUNTEERS; HUMAN BODIES; IMPLANT INFECTIONS; MODERN MEDICINE; STAPHYLOCOCCUS EPIDERMIDIS;

BLOOD;

CIPROFLOXACIN; CLINDAMYCIN; ERYTHROMYCIN; OXACILLIN; PENICILLIN G; TRIMETHOPRIM;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTERIUM ISOLATION; BIOFILM; BLOOD CULTURE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE DURATION; FEMALE; FEVER; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MICROTITER PLATE ASSAY; NONHUMAN; PROSTHESIS INFECTION; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS INFECTION; STATISTICAL SIGNIFICANCE; STRAIN DIFFERENCE; THROMBOCYTOPENIA; WILD TYPE;

EID: 30744462108     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880502801108     Document Type: Article

References (52)

1. Darouiche RO. Treatment of infections associated with surgical implants. N Engl J Med 2004; 350: 1422-9.
2. Siegenthaler MP, Martin J, Beyersdorf F. Mechanical circulatory assistance for acute and chronic heart failure: A review of current technology and clinical practice. J Interv Cardiol 2003; 16: 563-72.
3. Hebert CK, Williams RE, Levy RS, Barrack RL. Cost of treating an infected total knee replacement. Clin Orthop 1996; 140-5.
4. Pfaller MA, Herwaldt LA. Laboratory, clinical, and epidemiological aspects of coagulase-negative staphylococci. Clin Microbiol Rev 1988; 1: 281-99.
5. Pittet B, Montandon D, Pittet D. Infection in breast implants. Lancet Infect Dis 2005; 5: 94-106.
6. Bergamini TM, Bandyk DF, Govostis D, Kaebnick HW, Towne JB. Infection of vascular prostheses caused by bacterial biofilms. J Vasc Surg 1988; 7: 21-30.
7. Mack D, Rohde H, Dobinsky S, et al. Identification of three essential regulatory gene loci governing expression of Staphylococcus epidermidis polysaccharide intercellular adhesin and biofilm formation. Infect Immun 2000; 68: 3799-807.
8. Knobloch JK, Bartscht K, Sabottke A, Rohde H, Feucht HH, Mack D. Biofilm formation by Staphylococcus epidermidis depends on functional RsbU, an activator of the sigB operon: Differential activation mechanisms due to ethanol and salt stress. J Bacteriol 2001; 183: 2624-33.
9. Arciola CR, Campoccia D, Gamberini S, Donati ME, Baldassarri L, Montanaro L. Occurrence of ica genes for slime synthesis in a collection of Staphylococcus epidermidis strains from orthopedic prosthesis infections. Acta Orthop Scand 2003; 74: 617-21.
10. Fleer A, Verhoef J, Pascual HA. Coagulase-negative staphylococci as nosocomial pathogens in neonates. The role of host defense, artificial devices, and bacterial hydrophobicity. Am J Med 1986; 80: 161-5.
11. Nickoloff BJ, Turka LA. Immunological functions of nonprofessional antigen-presenting cells: New insights from studies of T-cell interactions with keratinocytes. Immunol Today 1994;15: 464-9.
12. Heinzelmann M, Herzig DO, Swain B, Mercer-Jones MA, Bergamini TM, Polk HC Jr. Phagocytosis and oxidative-burst response of planktonic Staphylococcus epidermidis RP62A and its non-slime-producing variant in human neutrophils. Clin Diagn Lab Immunol 1997; 4: 705-10.
13. Linderkamp O, Ruef P, Brenner B, Gulbins E, Lang F. Passive deformability of mature, immature, and active neutrophils in healthy and septicemic neonates. Pediatr Res 1998; 44: 946-50.
14. Maoleekoonpairoj S, Mittelman A, Savona S, et al. Lack of protection against bacterial infections in patients with advanced cancer treated by biologic response modifiers. J Clin Microbiol 1989; 27: 2305-8.
15. Takeda S, Pier GB, Kojima Y, et al. Protection against endocarditis due to Staphylococcus epidermidis by immunization with capsular polysaccharide/adhesin. Circulation 1991; 84: 2539-46.
16. Thylefors JD, Harbarth S, Pittet D. Increasing bacteremia due to coagulase-negative staphylococci: Fiction or reality? Infect Control Hosp Epidemiol 1998; 19: 581-9.
17. Weinstein MP, Towns ML, Quartey SM, et al. The clinical significance of positive blood cultures in the 1990s: A prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin Infect Dis 1997; 24: 584-602.
18. Souvenir D, Anderson DE Jr, Palpant S, et al. Blood cultures positive for coagulase-negative staphylococci: Antisepsis, pseudobacteremia, and therapy of patients. J Clin Microbiol 1998; 36: 1923-6.
19. Sharma M, Riederer K, Johnson LB, Khatib R. Molecular analysis of coagulase-negative Staphylococcus isolates from blood cultures: Prevalence of genotypic variation and polyclonal bacteremia. Clin Infect Dis 2001; 33: 1317-23.
20. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20: 864-74.
21. Murray PR, Baron EJ, Jorgensen JH, Pfaller MA, Yolken RH. Manual of Clinical Microbiology. Washington DC: ASM Press; 2003.
22. Hennekinne JA, Gohier M, Maire T, Lapeyre C, Lombard B, Dragacci S. First proficiency testing to evaluate the ability of European Union National Reference Laboratories to detect staphylococcal enterotoxins in milk products. J AOAC Int 2003; 86: 332-9.
23. Christensen GD, Baldassarri L, Simpson WA. Methods for studying microbial colonization of plastics. Methods Enzymol 1995; 253: 477-500.
24. Baldassarri L, Simpson WA, Donelli G, Christensen GD. Variable fixation of staphylococcal slime by different histochemical fixatives. Eur J Clin Microbiol Infect Dis 1993; 12: 866-8.
25. Pittet D, Wenzel RP. Nosocomial bloodstream infections. Secular trends in rates, mortality, and contribution to total hospital deaths. Arch Intern Med 1995; 155: 1177-84.
26. Laffer RR, Frei R, Widmer AF. [Epidemiology of septicemias in a university hospital over 5 yeaars]. Schweiz Med Wochenschr 2000; 130: 1471-8.
27. Darouiche RO. Antimicrobial approaches for preventing infections associated with surgical implants. Clin Infect Dis 2003; 36: 1284-9.
28. Trampuz A, Zimmerli W. New strategies for the treatment of infections associated with prosthetic joints. Curr Opin Investig Drugs 2005; 6: 185-90.
29. Basavaraj S, Najaraj S, Shanks M, Wardrop P, Allen AA. Short-term versus long-term antibiotic prophylaxis in cochlear implant surgery. Otol Neurotol 2004; 25: 720-2.
30. Roos-Jansaker AM, Renvert S, Egelberg J. Treatment of peri-implant infections: A literature review. J Clin Periodontol 2003; 30: 467-85.
31. Donlan RM, Costerton JW. Biofilms: Survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 2002; 15: 167-93.
32. Zimmerli W, Trampuz A, Ochsner PE. Prosthetic-joint infections. N Engl J Med 2004; 351: 1645-54.
33. Fisman DN, Reilly DT, Karchmer AW, Goldie SJ. Clinical effectiveness and cost-effectiveness of 2 management strategies for infected total hip arthroplasty in the elderly. Clin Infect Dis 2001; 32: 419-30.
34. Nimri LF, Rawashdeh M, Meqdam MM. Bacteremia in children: Etiologic agents, focal sites, and risk factors. J Trop Pediatr 2001; 47: 356-60.
35. Fidalgo S, Vazquez F, Mendoza MC, Perez F, Mendez FJ. Bacteremia due to Staphylococcus epidermidis: Microbiologic, epidemiologic, clinical, and prognostic features. Rev Infect Dis 1990; 12: 520-8.
36. Lina B, Forey F, Tigaud JD, Fleurette J. Chronic bacteraemia due to Staphylococcus epidermidis after bone marrow transplantation. J Med Microbiol 1995; 42: 156-60.
37. Richards MJ, Edwards JR, Culver DH, Gaynes RP. Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. Crit Care Med 1999; 27: 887-92.
38. Khatib R, Riederer KM, Clark JA, Khatib S, Briski LE, Wilson FM. Coagulase-negative staphylococci in multiple blood cultures: Strain relatedness and determinants of same-strain bacteremia. J Clin Microbiol 1995; 33: 816-20.
39. Mermel LA, Farr BM, Sherertz RJ, et al. Guidelines for the management of intravascular catheter-related infections. J Intraven Nurs 2001; 24: 180-205.
40. Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis: Diagnosis, antimicrobial therapy, and management of complications: A statement for healthcare professionals from the committee on rheumatic fever, endocarditis, and Kawasaki disease, council on cardiovascular disease in the young, and the councils on clinical cardiology, stroke, and cardiovascular surgery and anesthesia, American Heart Association-executive summary: Endorsed by the Infectious Diseases Society of America. Circulation 2005; 111: 3167-84.
41. Donlan RM. Biofilms and device-associated infections. Emerg Infect Dis 2001; 7: 277-81.
42. Vandecasteele SJ, Peetermans WE, Merckx R, Van EJ. Expression of biofilm-associated genes in Staphylococcus epidermidis during in vitro and in vivo foreign body infections. J Infect Dis 2003; 188: 730-7.
43. Tacconelli E, Tumbarello M, Donati KG, et al. Glycopeptide resistance among coagulase-negative staphylococci that cause bacteremia: Epidemiological and clinical findings from a case-control study. Clin Infect Dis 2001; 33: 1628-35.
44. Ponce de LS, Guenthner SH, Wenzel RP. Microbiologic studies of coagulase-negative staphylococci isolated from patients with nosocomial bacteraemias. J Hosp Infect 1986; 7: 121-9.
45. Ziebuhr W, Heilmann C, Gotz F, et al. Detection of the intercellular adhesion gene cluster (ica) and phase variation in Staphylococcus epidermidis blood culture strains and mucosal isolates. Infect Immun 1997; 65: 890-6.
46. Vandecasteele SJ, Peetermans WE, Merckx R, Rijnders BJ, Van EJ. Reliability of the ica, aap and atlE genes in the discrimination between invasive, colonizing and contaminant Staphylococcus epidermidis isolates in the diagnosis of catheter-related infections. Clin Microbiol Infect 2003; 9: 114-9.
47. Knobloch JK, Horstkotte MA, Rohde H, Kaulfers PM, Mack D. Alcoholic ingredients in skin disinfectants increase biofilm expression of Staphylococcus epidermidis. J Antimicrob Chemother 2002; 49: 683-7.
48. Buxbaum A, Straschil U, Moser C, Graninger W, Georgopoulos A. Comparative susceptibility to penicillin and quinolones of 1385 Streptococcus pneumoniae isolates. J Antimicrob Chemother 1999; 43 (suppl B): S13-8.
49. Thakker-Varia S, Jenssen WD, Moon-McDermott L, Weinstein MP, Dubin DT. Molecular epidemiology of macrolides-lincosamides-streptogramin B resistance in Staphylococcus aureus and coagulase-negative staphylococci. Antimicrob Agents Chemother 1987; 31: 735-43.
50. Joukhadar C, Klein N, Dittrich P, et al. Target site penetration of fosfomycin in critically ill patients. J Antimicrob Chemother 2003; 51: 1247-52.
51. Olsson-Liljequist B, Burman LG. Introducing fosfomycin for surgical prophylaxis - emergence of resistance in aerobic faecal gram-negative bacteria of in-patients, but not among strains causing infection after elective colorectal procedures. Scand J Infect Dis 1993; 25: 725-33.
52. Trautner BW, Darouiche RO. Catheter-associated infections: Pathogenesis affects prevention. Arch Intern Med 2004; 164: 842-50.